Nplate News
Most Popular Nplate Story
FDA approves Amgen's Nplate
Amgen has received FDA approval for Nplate for the treatment of immune thrombocytopenic purpura (ITP). ITP is a bleeding condition--which affects about 60,000 people in the U.S.-- that causes the... Read more...
Latest Headlines
- August 25, 2008
- July 22, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
